A cohort of 17 patients with kyphoscoliotic Ehlers–Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history

Autor: Giunta, Cecilia, Baumann, Matthias, Fauth, Christine, Lindert, Uschi, Abdalla, Ebtesam M., Brady, Angela F., Collins, James, Dastgir, Jahannaz, Donkervoort, Sandra, Ghali, Neeti, Johnson, Diana S., Kariminejad, Ariana, Koch, Johannes, Kraenzlin, Marius, Lahiri, Nayana, Lozic, Bernarda, Manzur, Adnan Y., Morton, Jenny E.V., Pilch, Jacek, Pollitt, Rebecca C., Schreiber, Gudrun, Shannon, Nora L., Sobey, Glenda, Vandersteen, Anthony, van Dijk, Fleur S., Witsch-Baumgartner, Martina, Zschocke, Johannes, Pope, F. Michael, Bönnemann, Carsten G., Rohrbach, Marianne
Zdroj: Genetics in Medicine; January 2018, Vol. 20 Issue: 1 p42-54, 13p
Abstrakt: In 2012 we reported in six individuals a clinical condition almost indistinguishable from PLOD1-kyphoscoliotic Ehlers–Danlos syndrome (PLOD1-kEDS), caused by biallelic mutations in FKBP14, and characterized by progressive kyphoscoliosis, myopathy, and hearing loss in addition to connective tissue abnormalities such as joint hypermobility and hyperelastic skin. FKBP14 is an ER-resident protein belonging to the family of FK506-binding peptidyl-prolyl cis–transisomerases (PPIases); it catalyzes the folding of type III collagen and interacts with type III, type VI, and type X collagens. Only nine affected individuals have been reported to date.
Databáze: Supplemental Index
Externí odkaz: